-
), one of Canada's leading neuroscience research centres. The successful candidate will develop next-generation human experimental models to investigate the cellular and molecular mechanisms underlying
-
. The Sun Lab uses multidisciplinary approaches, spanning microbial genetics, cell biology, immunology, high-throughput screening, omics, and in vivo models, to study host immunity to pathogens (such as
-
at the molecular and tissue level, and how its disruption contributes to hereditary cancers and pediatric malignancies (https://bcchr.ca/maxwell-lab ). Key areas include: Mechanisms of cell division fidelity
-
Research Institute and UBC, investigates how cell division is regulated at the molecular and tissue level, and how its disruption contributes to hereditary cancers and pediatric malignancies (https
-
regulated at the molecular and tissue level, and how its disruption contributes to hereditary cancers and pediatric malignancies (https://bcchr.ca/maxwell-lab ). Key areas include: Mechanisms of cell
-
. in Chemistry, Molecular Biology, Biochemistry, Cell Biology, Bioengineering, Material Science, or a related field. Deep technical expertise in recombinant protein design, cloning, and FPLC/HPLC protein
-
mouse models relevant to MS pathogenesis and recovery. Performing and overseeing cellular and molecular studies involving macrophages, microglia, and other CNS-resident or infiltrating immune cells
-
of endometriosis to clear cell and/or endometrioid ovarian carcinomas. This work will form the basis of prevention, treatment, and etiological understanding of disease. The successful candidate will work within a
-
Research) at the University of British Columbia is seeking a highly motivated Postdoctoral Fellow to study the process driving malignant transformation of endometriosis to clear cell and/or endometrioid
-
University of British Columbia Department of Surgery | Northern British Columbia Fort Nelson, British Columbia | Canada | about 2 months ago
multidisciplinary team Experience in research using relevant techniques will be an asset: cell or gene therapy culture ;Animal models of immune disease; Genome engineering Lipid nanoparticle technologies; Synthetic